A novel titin mutation in adult-onset familial dilated cardiomyopathy

American Journal of Cardiology

Volumn 109, Issue 11, 2012, Pages 1644-1650

  Yoskovitz, Guy ^a   Peled, Yael ^a   Gramlich, Michael ^b   Lahat, Hadas ^a   Resnik Wolf, Heike ^a   Feinberg, Micha S ^a   Afek, Arnon ^a   Pras, Elon ^a   Arad, Michael ^a   Gerull, Brenda ^b,c   Freimark, Dov ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CONNECTIN;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; CHROMOSOME 2Q; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FAMILY HISTORY; FEMALE; GENE EXPRESSION; GENE INSERTION; GENE LOCATION; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; HEART LEFT ATRIUM; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE SEPTUM; HUMAN; LINKAGE ANALYSIS; MALE; PATIENT REFERRAL; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION;

ADULT; ARABS; CARDIOMYOPATHY, DILATED; CHROMOSOMES, HUMAN, PAIR 2; FEMALE; FRAMESHIFT MUTATION; GENETIC LINKAGE; HAPLOTYPES; HUMANS; ISRAEL; MALE; MIDDLE AGED; MUSCLE PROTEINS; PEDIGREE; PROTEIN KINASES;

EID: 84861184354     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.01.392     Document Type: Article

References (27)

1. H. Morita, J. Seidman, C.E. Seidman Genetic causes of human heart failure J Clin Invest 115 2005 518 526
2. J.L. Jefferies, J.A. Towbin Dilated cardiomyopathy Lancet 375 2010 752 762
3. A.N. Chang, J.D. Potter Sarcomeric protein mutations in dilated cardiomyopathy Heart Fail Rev 10 2005 225 235
4. R. Knöll, M. Hoshijima, H.M. Hoffman, V. Person, I. Lorenzen-Schmidt, M.L. Bang, T. Hayashi, N. Shiga, H. Yasukawa, W. Schaper, W. McKenna, M. Yokoyama, N.J. Schork, J.H. Omens, A.D. McCulloch, A. Kimura, C.C. Gregorio, W. Poller, J. Schaper, H.P. Schultheiss, K.R. Chien The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy Cell 111 2002 943 955
5. B. Gerull, M. Gramlich, Atherton, M. McNabb, K. Trombitás, S. Sasse-Klaassen, J.G. Seidman, C. Seidman, H. Granzier, S. Labeit, M. Frenneaux, L. Thierfelder Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy Nat Genet 30 2002 201 204
6. B. Gerull, J. Atherton, A. Geupel, S. Sasse-Klaassen, A. Heuser, M. Frenneaux, M. McNabb, H. Granzier, S. Labeit, L. Thierfelder Identification of a novel frameshift mutation in the giant muscle filament titin in a large Australian family with dilated cardiomyopathy J Mol Med 84 2006 478 483
7. L. Mestroni, B. Maisch, McKenna, K. Schwartz, P. Charron, C. Rocco, F. Tesson, A. Richter, A. Wilke, M. Komajda Guidelines for the study of familial dilated cardiomyopathies Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy Eur Heart J 20 1999 93 102
8. B.J. Maron, J.A. Towbin, G. Thiene, C. Antzelevitch, D. Corrado, D. Arnett, A.J. Moss, C.E. Seidman, J.B. Young American Heart Association, Council on Clinical Cardiology, Heart Failure and Transplantation Committee, Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups, Council on Epidemiology and Prevention Contemporary definitions and classification of the cardiomyopathies: an American Heart Association scientific statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention Circulation 113 2006 1807 1816
9. W.C. Levy, D. Mozaffarian, D.T. Linker, S.C. Sutradhar, S.D. Anker, A.B. Cropp, I. Anand, A. Maggioni, P. Burton, M.D. Sullivan, B. Pitt, P.A. Poole-Wilson, D.L. Mann, M. Packer The Seattle Heart Failure Model: prediction of survival in heart failure Circulation 113 2006 1424 1433
10. K. Swedberg, J. Kjekshus Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS) Am J Cardiol 62 1988 60A 66A
11. The SOLVD Investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure N Engl J Med 325 1991 293 302
12. M.A. Pfeffer, E. Braunwald, L.A. Moyé, L. Basta, E.J. Brown Jr, T.E. Cuddy, B.R. Davis, E.M. Geltman, S. Goldman, G.C. Flaker, M. Klein, G.A. Lamas, M. Packer, J. Rouleau, J.L. Rouleau, J. Rutherford, J.H. Wertheimer, M. Hawkins Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial The SAVE investigators N Engl J Med 327 1992 669 677
13. B. Pitt, R. Segal, F.A. Martinez, G. Meurers, A.J. Cowley, I. Thomas, P.C. Deedwania, D.E. Ney, D.B. Snavely, P.I. Chang Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE) Lancet 349 1997 747 752
14. B. Pitt, P.A. Poole-Wilson, R. Segal, F.A. Martinez, K. Dickstein, A.J. Camm, M.A. Konstam, G. Riegger, G.H. Klinger, J. Neaton, D. Sharma, B. Thiyagarajan Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial - the Losartan Heart Failure Survival Study ELITE II Lancet 355 2000 1582 1587
15. J.N. Cohn, G. Tognoni Valsartan Heart Failure Trial Investigators A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure N Engl J Med 345 2001 1667 1675
16. M.A. Pfeffer, K. Swedberg, C.B. Granger, P. Held, J.J. McMurray, E.L. Michelson, B. Olofsson, J. Ostergren, S. Yusuf, S. Pocock CHARM Investigators and Committees Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme Lancet 362 2003 759 766
17. K. Dickstein, J. Kjekshus OPTIMAAL Steering Committee of the OPTIMAAL Study Group Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan Lancet 360 2002 752 760
18. M. Packer, A.J. Coats, M.B. Fowler, H.A. Katus, H. Krum, P. Mohacsi, J.L. Rouleau, M. Tendera, A. Castaigne, E.B. Roecker, M.K. Schultz, D.L. DeMets Carvedilol Prospective Randomized Cumulative Survival Study Group Effect of carvedilol on survival in severe chronic heart failure effect of carvedilol on survival in severe chronic heart failure N Engl J Med 344 2001 1651 1658
19. M. Dandel, R. Hetzer Echocardiographic strain and strain rate imaging-clinical applications Int J Cardiol 132 2009 11 24
20. R.E. Hershberger, J. Lindenfeld, L. Mestroni, C.E. Seidman, M.R. Taylor, J.A. Towbin Heart Failure Society of America Genetic evaluation of cardiomyopathy - a Heart Failure Society of America practice guideline J Card Fail 15 2009 83 97
21. D. Duboc, C. Meune, G. Lerebours, J.Y. Devaux, G. Vaksmann, H.M. Bécane Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy J Am Coll Cardiol 45 2005 855 857
22. D. Duboc, C. Meune, B. Pierre, K. Wahbi, B. Eymard, A. Toutain, C. Berard, G. Vaksmann, S. Weber, H.M. Bécane Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years' follow-up Am Heart J 154 2007 596 602
23. P. Hackman, A. Vihola, H. Haravuori, S. Marchand, J. Sarparanta, J. De Seze, S. Labeit, C. Witt, L. Peltonen, I. Richard, B. Udd Tibial muscular dystrophy is a titinopathy caused by mutations in TTN, the gene encoding the giant skeletal-muscle protein titin Am J Hum Genet 71 2002 492 500
24. S. Lange, F. Xiang, A. Yakovenko, A. Vihola, P. Hackman, E. Rostkova, J. Kristensen, B. Brandmeier, G. Franzen, B. Hedberg, L.G. Gunnarsson, S.M. Hughes, S. Marchand, T. Sejersen, I. Richard, L. Edström, E. Ehler, B. Udd, M. Gautel The kinase domain of titin controls muscle gene expression and protein turnover Science 308 2005 1599 1603
25. M. Itoh-Satoh, T. Hayashi, H. Nishi, Y. Koga, T. Arimura, T. Koyanagi, M. Takahashi, S. Hohda, K. Ueda, T. Nouchi, M. Hiroe, F. Marumo, T. Imaizumi, M. Yasunami, A. Kimura Titin mutations as the molecular basis for dilated cardiomyopathy Biochem Biophys Res Commun 291 2002 385 393
26. V. Carmignac, M.A. Salih, S. Quijano-Roy, S. Marchand, M.M. Al Rayess, M.M. Mukhtar, J.A. Urtizberea, S. Labeit, P. Guicheney, F. Leturcq, M. Gautel, M. Fardeau, K.P. Campbell, I. Richard, B. Estournet, A. Ferreiro C-terminal titin deletions cause a novel early-onset myopathy with fatal cardiomyopathy Ann Neurol 61 2007 340 351
27. M. Gramlich, B. Michely, C. Krohne, A. Heuser, B. Erdmann, S. Klaassen, B. Hudson, M. Magarin, F. Kirchner, M. Todiras, H. Granzier, S. Labeit, L. Thierfelder, B. Gerull Stress-induced dilated cardiomyopathy in a knock-in mouse model mimicking human titin-based disease J Mol Cell Cardiol 47 2009 352 358